What Happened?
, -based Renalytix Promoted Justin DiVenuta as Regional Sales Director
About the Company
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) is the global founder and leader in the new field of bioprognosisTM for kidney health. The company has engineered a new solution that successfully enables early-stage chronic kidney disease, progression risk assessment. The Company`s lead product, KidneyIntelX, has been granted Breakthrough Designation by the U.S. Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
About the Person
Justin DiVenuta is Regional Sales Director at Renalytix. Previously, Justin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile